Theranica, a Montclair, N.J.-based migraine-focused digital therapeutics company, raised $45 million in Series C funding, per Fortune’s Term Sheet. New Rhein Healthcare Investors led the round and was joined by investors including aMoon, Lightspeed Venture Partners, LionBird, Takoa Invest, and Corundum Open Innovation.
Related Posts
Cohen Foundation Gifts $35M to NewYork-Presbyterian Pediatric Behavioral Health Unit
According to NewYork-Presbyterian, the funds will be used to expand child and adolescent inpatient units and create a state-of-the-art ambulatory behavioral health center at NewYork-Presbyterian Westchester Behavioral Health in White Plains.
July 10, 2023
New AHA Center for Telehealth to Increase Access to Care and Improve Delivery
Made possible by a $15.9 million grant from The Leona M. and Harry B. Helmsley Charitable Trust, the AHA Center for Telehealth will provide telehealth education and resources through collaboration with the telehealth community.
November 13, 2023
Luke & Associates Secures Investment from M33 Growth
Luke & Associates provides healthcare services to the federal government and commercial entities including the military, their families and veterans.
December 19, 2022
NIH Awards $23M for Telehealth Oncology
Under the federal Cancer Moonshot initiative, the TRACE program is focused on how best to use and sustain telehealth to provide cancer-related care.
August 31, 2022